SSCP pattern indicative for p53 mutation is related to advanced stage and high-grade of tongue cancer

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 4, 1996, Pages 222-229

  Atula, S ^a   Kurvinen, K ^a   Grenman R ^b   Syrjanen S ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MUTATION; NECK METASTASIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING; TONGUE CANCER;

EID: 0030201001     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/0964-1955(96)00022-X     Document Type: Article

References (35)

1. 1. Lindberg RD. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tract. Cancer 1972, 29, 1446-1449.
2. 2. Ildstad ST, Bigelow ME, Remensnyder JP. Squamous cell carcinoma of the tongue: a comparison of the anterior two thirds of the tongue with its base. Am J Surg 1983, 146, 456-461.
3. 3. Chang F, Syrjänen S, Syrjänen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol 1995, 13, 1009-1022.
4. 4. Lowe SW, Bodis S, McClatchey A, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994, 266, 807-810.
5. 5. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74, 957-967.
6. 6. Park N-H, Li S-L, Xie J-F, Cherrick HM. In vitro and animal studies of the role of viruses in oral carcinogenesis. Oral Oncol, Eur J Cancer 1992, 28B, 145-152.
7. 7. Ryan JJ, Prochownik E, Gottlieb CA, et al. C-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA 1994, 91, 5878-5882.
8. 8. Zariwala M, Schmid S, Pfaltz M, Ohgaki H, Kleihues P, Schäfer R. p53 gene mutations in oropharyngeal carcinomas: a comparison of solitary and multiple primary tumours and lymph-node metastases. Int J Cancer 1994, 56, 807-811.
9. 9. Leedy DA, Trune DR, Kronz JD, Weidner J, Cohen JI. Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue. Otolaryngol Head Neck Surg 1994, 111, 417-122.
10. 10. Ahomadegbe JC, Barrois M, Fogel S, et al. High incidence of p53 alterations in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesion. Oncogene 1995, 10, 1217-1227.
11. 11. Suzuki H, Takahashi T, Kuroishi T, et al. p53 mutations in non-small cell lung cancer in Japan : association between mutations and smoking. Cancer Res 1992, 52, 734-736.
12. 12. Wang X, Christiani DC, Wiencke JK, et al. Mutations in the p53 gene in lung cancer are associated with cigarette smoking and asbestos exposure. Cancer Epidemiol Biomarkers Prev 1995, 4, 543-548.
13. 13. Field JK, Spandidos JA, Malliri A, Gosney JR, Yiagnisis M, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991, 64, 573-577.
14. 14. Matthews JB, Scully C, Jovanovic A, Van der Waal I, Yeudall WA, Prime SS. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carcinomas. Oral Oncol, Eur J Cancer 1993, 29B, 285-289.
15. 15. Miyashita T, Krajewski S, Krajewska M, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9, 1799-1805.
16. 16. Lu Q-L, Elia G, Lucas S, Thomas JA. Bcl-2 proto-oncogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int J Cancer 1993, 53, 29-35.
17. 17. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y. Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 1994, 54, 6-8.
18. 18. Yunis JJ, Mayer MG, Arnesen MA, Aeppli DP, Oken MM, Frizzera G. Bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. N Engl J Med 1989, 320, 1047-1054.
19. 19. Bell DA, Liu Y, Cortopassi GA. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J Natl Cancer Inst 1995, 87, 223-224.
20. 20. Gallo O, Bianchi S, Porfirio B. Bcl-2 overexpression and smoking history in head and neck cancer. J Natl Cancer Inst 1995, 87, 1024-1025.
21. 21. Kurvinen K, Hietanen S, Syrjänen K, Syrjänen S. Rapid and effective detection of mutations in the p53 gene using nonradioactive single-strand conformation polymorphism (SSCP) technique applied on PhastSystem™. J Virol Meth 1995, 51, 43-54.
22. 22. Moyret C, Theulet C, Puig PL, Moles JP, Thomas G, Hamelin R. Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene. Oncogene 1994, 9, 1739-1743.
23. 23. Sameshima Y, Matsuno Y, Hirohashi S, et al. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 1992, 7, 451-457.
24. 24. Pohl J, Goldfinger N, Radler-Pohl A, Rotter V, Schirrmacher V. p53 increases experimental metastatic capacity of murine carcinoma cells. Mol Cell Biol 1992, 8, 2078-2081.
25. 25. Vogelstein B. A deadly inheritance. Nature 1990, 348, 681-682.
26. 26. Scarpa A, Capelli P, Mukai K, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Path 1993, 142, 1534-1543.
27. 27. Kennedy SM, MacGeogh C, Jaffe R, Spurr NK. Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum Pathol 1994, 25, 438-442.
28. 28. Lu Q-L, Hanby AM, Hajibagheri MAN, et al. Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J Cell Sci 1994, 107, 363-371.
29. 29. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993, 74, 609-619.
30. 30. Burns JE, Baird MC, Clark LJ, et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993, 67, 1274-1284.
31. 31. Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 1992, 7, 927-933.
32. 32. Brachman DG, Graves D, Yokes E, et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992, 52, 4832-4836.
33. 33. Mitsudomi T, Steinberg SM, Nau MM, et al. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 1992, 7, 171-180.
34. 34. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995, 332, 712-717.
35. 35. Field JK, Spandidos DA, Stell PM. Overexpression of p53 gene in head-and-neck cancer, linked with heavy smoking and drinking. Lancet 1992, 339, 502-503.